Cargando…

Update on Hemicrania Continua

Hemicrania continua (HC) is a rare primary headache syndrome, characterized by unilateral pain and an absolute response to indometacin. Since the term was first coined in 1984, more than 100 cases have been described worldwide. Most recently, detailed case series that provide more detailed informati...

Descripción completa

Detalles Bibliográficos
Autores principales: Cittadini, Elisabetta, Goadsby, Peter J.
Formato: Texto
Lenguaje:English
Publicado: Current Science Inc. 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021804/
https://www.ncbi.nlm.nih.gov/pubmed/21080113
http://dx.doi.org/10.1007/s11916-010-0156-0
_version_ 1782196419713564672
author Cittadini, Elisabetta
Goadsby, Peter J.
author_facet Cittadini, Elisabetta
Goadsby, Peter J.
author_sort Cittadini, Elisabetta
collection PubMed
description Hemicrania continua (HC) is a rare primary headache syndrome, characterized by unilateral pain and an absolute response to indometacin. Since the term was first coined in 1984, more than 100 cases have been described worldwide. Most recently, detailed case series that provide more detailed information concerning the sometimes complex clinical presentation of HC have been reported. Functional imaging studies suggest a unique pattern of subcortical involvement in HC: contralateral to the pain posterior hypothalamic region, ipsilateral dorsal pons and ipsilateral ventral midbrain, which, along with the particular effect of indometacin, probably justifies its classification as a unique entity. Increasing the awareness of this primary headache form among clinicians will aid in its diagnosis while further work is being undertaken to characterize the syndrome.
format Text
id pubmed-3021804
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Current Science Inc.
record_format MEDLINE/PubMed
spelling pubmed-30218042011-01-31 Update on Hemicrania Continua Cittadini, Elisabetta Goadsby, Peter J. Curr Pain Headache Rep Article Hemicrania continua (HC) is a rare primary headache syndrome, characterized by unilateral pain and an absolute response to indometacin. Since the term was first coined in 1984, more than 100 cases have been described worldwide. Most recently, detailed case series that provide more detailed information concerning the sometimes complex clinical presentation of HC have been reported. Functional imaging studies suggest a unique pattern of subcortical involvement in HC: contralateral to the pain posterior hypothalamic region, ipsilateral dorsal pons and ipsilateral ventral midbrain, which, along with the particular effect of indometacin, probably justifies its classification as a unique entity. Increasing the awareness of this primary headache form among clinicians will aid in its diagnosis while further work is being undertaken to characterize the syndrome. Current Science Inc. 2010-11-16 2011 /pmc/articles/PMC3021804/ /pubmed/21080113 http://dx.doi.org/10.1007/s11916-010-0156-0 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Cittadini, Elisabetta
Goadsby, Peter J.
Update on Hemicrania Continua
title Update on Hemicrania Continua
title_full Update on Hemicrania Continua
title_fullStr Update on Hemicrania Continua
title_full_unstemmed Update on Hemicrania Continua
title_short Update on Hemicrania Continua
title_sort update on hemicrania continua
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021804/
https://www.ncbi.nlm.nih.gov/pubmed/21080113
http://dx.doi.org/10.1007/s11916-010-0156-0
work_keys_str_mv AT cittadinielisabetta updateonhemicraniacontinua
AT goadsbypeterj updateonhemicraniacontinua